Aemetis, Inc. (NASDAQ:AMTX) Shares Acquired by Barclays PLC

Barclays PLC lifted its stake in Aemetis, Inc. (NASDAQ:AMTX) by 274.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,496 shares of the specialty chemicals company’s stock after purchasing an additional 34,816 shares during the period. Barclays PLC owned about 0.10% of Aemetis worth $109,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of AMTX. FMR LLC boosted its holdings in Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. Rhumbline Advisers boosted its holdings in Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 50,528 shares during the period. Wellington Management Group LLP purchased a new position in Aemetis in the third quarter valued at $177,000. Bank of New York Mellon Corp purchased a new position in Aemetis in the second quarter valued at $306,000. Finally, Susquehanna Fundamental Investments LLC boosted its holdings in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the period. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Price Performance

Shares of NASDAQ AMTX opened at $2.82 on Thursday. Aemetis, Inc. has a 1 year low of $2.10 and a 1 year high of $7.03. The company has a market capitalization of $140.25 million, a price-to-earnings ratio of -1.25 and a beta of 1.47. The business has a 50-day moving average of $3.28 and a two-hundred day moving average of $2.97.

Aemetis (NASDAQ:AMTX) last posted its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analysts’ expectations of $77.79 million. During the same period in the previous year, the firm posted ($0.59) earnings per share. As a group, equities research analysts expect that Aemetis, Inc. will post -2.02 earnings per share for the current year.

Analyst Upgrades and Downgrades

AMTX has been the subject of a number of recent analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. StockNews.com raised Aemetis to a “sell” rating in a report on Friday, January 3rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.